Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
GLSI | US
-4.22
-14.80%
Healthcare
Biotechnology
30/06/2024
02/06/2026
24.29
27.01
27.38
22.00
Greenwich LifeSciences Inc. a clinical-stage biopharmaceutical company focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2 an immunotherapy which is in Phase III clinical trial to prevent breast cancer recurrences in patients who have previously undergone surgery. The company was formerly known as Norwell Inc. and changed its name to Greenwich LifeSciences Inc. in March 2018. Greenwich LifeSciences Inc. was incorporated in 2006 and is headquartered in Stafford Texas.
View LessStrong Sharpe Ratio (> 1.2)
Weakness based on declining price with high volume
Price Below SMA10D
High Short-term Volatility
High 6-Month Volatility (>65%)
High Current Volume and Negative 1-Day Return
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
Rich in Valuation (Price to Book > 8)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
113.0%1 month
88.2%3 months
92.5%6 months
119.0%-
-
31.77
-
-
-21.23
-
-
-10.53M
319.28M
319.28M
-
-
-
-
-123.67
11.82
7.78
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
7.93
Range1M
8.52
Range3M
9.73
Rel. volume
3.18
Price X volume
11.56M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Veru Inc | VERU | Drug Manufacturers-Specialty & Generic | 2.35 | 344.00M | -1.26% | n/a | 36.36% |
| Puma Biotechnology Inc | PBYI | Biotechnology | 6.98 | 342.35M | -1.97% | 15.16 | 203.23% |
| Nautilus Biotechnology Inc. | NAUT | Biotechnology | 2.68 | 336.10M | -3.25% | n/a | 13.86% |
| Aclaris Therapeutics Inc | ACRS | Biotechnology | 4.63 | 330.33M | 6.68% | n/a | 2.10% |
| REGENXBIO Inc | RGNX | Biotechnology | 6.52 | 322.24M | -8.68% | n/a | 45.57% |
| Cipher Pharmaceuticals Inc | CPHRF | Drug Manufacturers-Specialty & Generic | 12.18 | 311.36M | -0.16% | 13.22 | 0.00% |
| OABI | OABI | Biotechnology | 2.62 | 309.59M | 0.38% | n/a | 8.27% |
| SIGA Technologies Inc | SIGA | Biotechnology | 4.32 | 308.32M | -2.70% | 5.91 | 0.97% |
| ADC Therapeutics SA | ADCT | Biotechnology | 3.17 | 306.50M | -6.76% | n/a | -94.48% |
| ProMIS Neurosciences Inc. | PMN | Biotechnology | 10.15 | 303.34M | -2.50% | n/a | 0.00% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Camping World Holdings Inc | CWH | Recreational Vehicles | 7.44 | 335.76M | -1.06% | n/a | 3644.76% |
| Urban One Inc | UONEK | Broadcasting - Radio | 4.7 | 249.14M | -10.36% | n/a | 268.43% |
| CPI Card Group Inc | PMTS | Building Products & Equipment | 16.74 | 186.78M | -0.42% | 15.61 | -621.78% |
| ONEWATER MARINE INC. | ONEW | Recreational Vehicles | 11.36 | 182.41M | 2.53% | n/a | 286.96% |
| Kewaunee Scientific Corporation | KEQU | Building Products & Equipment | 40.57 | 116.51M | -0.44% | 5.16 | 19.82% |
| Virco Mfg. Corporation | VIRC | Building Products & Equipment | 6.01 | 97.90M | 0.84% | 9.09 | 39.79% |
| Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 7.09 | 67.49M | 2.75% | n/a | 19.98% |
| ILAG | ILAG | Building Products & Equipment | 3.6016 | 65.04M | -4.21% | n/a | 5.48% |
| Saga Communications Inc | SGA | Broadcasting - Radio | 9.37 | 58.67M | -0.64% | 14.48 | 7.10% |
| Beasley Broadcast Group Inc | BBGI | Broadcasting - Radio | 19.59 | 29.83M | 25.34% | n/a | 204.46% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -21.23 | - | Cheaper |
| Ent. to Revenue | - | - | - |
| PE Ratio | - | 41.03 | - |
| Price to Book | 31.77 | 15.55 | Expensive |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 92.48 | - | Riskier |
| Debt to Equity | - | -1.23 | - |
| Debt to Assets | - | 0.25 | - |
| Market Cap | 319.28M | - | Emerging |